• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

垂体肿瘤的发病机制。

The pathogenesis of pituitary tumors.

作者信息

Asa Sylvia L, Ezzat Shereen

机构信息

Department of Laboratory Medicine and Pathobiology, University of Toronto, University Health Network and Ontario Cancer Institute, Toronto, Ontario, Canada.

出版信息

Annu Rev Pathol. 2009;4:97-126. doi: 10.1146/annurev.pathol.4.110807.092259.

DOI:10.1146/annurev.pathol.4.110807.092259
PMID:19400692
Abstract

Recently there has been significant progress in our understanding of pituitary development, physiology, and pathology. New information has helped to clarify the classification of pituitary tumors. Epidemiologic analyses have identified a much higher incidence of pituitary tumors than previously thought. We review the pathogenetic factors that have been implicated in pituitary tumorigenesis and the application of novel targeted therapies that underscore the increasingly important role of the pathologist in determining accurate diagnoses and facilitating appropriate treatment of patients with these disorders.

摘要

最近,我们对垂体发育、生理学和病理学的理解取得了重大进展。新信息有助于明确垂体肿瘤的分类。流行病学分析发现垂体肿瘤的发病率比之前认为的要高得多。我们回顾了与垂体肿瘤发生相关的致病因素,以及新型靶向治疗的应用,这些都凸显了病理学家在准确诊断和促进这些疾病患者的适当治疗方面日益重要的作用。

相似文献

1
The pathogenesis of pituitary tumors.垂体肿瘤的发病机制。
Annu Rev Pathol. 2009;4:97-126. doi: 10.1146/annurev.pathol.4.110807.092259.
2
The molecular pathogenesis of pituitary tumors: implications for clinical management.垂体肿瘤的分子发病机制:对临床管理的启示
Minerva Endocrinol. 2012 Jun;37(2):157-72.
3
Corticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX Mutations.促皮质素细胞侵袭性垂体肿瘤和癌常携带 ATRX 突变。
J Clin Endocrinol Metab. 2021 Mar 25;106(4):1183-1194. doi: 10.1210/clinem/dgaa749.
4
Pituitary stem cells: review of the literature and current understanding.垂体干细胞:文献回顾与当前认识。
Neurosurgery. 2010 Sep;67(3):770-80. doi: 10.1227/01.NEU.0000373013.75994.CD.
5
Recent progress in studies of pituitary tumor pathogenesis.垂体肿瘤发病机制的研究进展
Endocrine. 2005 Oct;28(1):37-41. doi: 10.1385/ENDO:28:1:037.
6
Pituitary adenoma pathogenesis: an update.垂体腺瘤发病机制的研究进展。
Curr Opin Endocrinol Diabetes Obes. 2012 Aug;19(4):322-7. doi: 10.1097/MED.0b013e328354b2e2.
7
The pathogenesis of pituitary tumours.垂体肿瘤的发病机制。
Nat Rev Cancer. 2002 Nov;2(11):836-49. doi: 10.1038/nrc926.
8
Pathology of acromegaly.肢端肥大症的病理学
Neuroendocrinology. 2006;83(3-4):161-5. doi: 10.1159/000095524. Epub 2006 Oct 13.
9
The pathology of pituitary tumors.
Endocrinol Metab Clin North Am. 1999 Mar;28(1):13-43, v-vi. doi: 10.1016/s0889-8529(05)70056-6.
10
MicroRNAs: Suggested role in pituitary adenoma pathogenesis.微小 RNA:在垂体腺瘤发病机制中的作用。
J Endocrinol Invest. 2013 Nov;36(10):889-95. doi: 10.1007/BF03346759.

引用本文的文献

1
Air Pollution and Pituitary Adenoma Pathogenesis: Unraveling Environmental Impacts on Neuroendocrine Function and Tumorigenesis.空气污染与垂体腺瘤发病机制:揭示环境对神经内分泌功能及肿瘤发生的影响
J Xenobiot. 2025 May 12;15(3):71. doi: 10.3390/jox15030071.
2
Refining Endoscopic and Combined Surgical Strategies for Giant Pituitary Adenomas: A Tertiary-Center Evaluation of 49 Cases over the Past Year.优化巨大垂体腺瘤的内镜及联合手术策略:对过去一年49例病例的三级中心评估
Cancers (Basel). 2025 Mar 26;17(7):1107. doi: 10.3390/cancers17071107.
3
Fibrous bodies in pituitary adenoma.
垂体腺瘤中的纤维小体。
Med J Armed Forces India. 2024 Dec;80(Suppl 1):S430-S432. doi: 10.1016/j.mjafi.2024.02.005. Epub 2024 Apr 8.
4
scRNA sequencing technology for PitNET studies.用于垂体神经内分泌肿瘤(PitNET)研究的单细胞RNA测序技术。
Front Endocrinol (Lausanne). 2024 Jul 24;15:1414223. doi: 10.3389/fendo.2024.1414223. eCollection 2024.
5
Headache in patients with non-functioning pituitary adenoma before and after transsphenoidal surgery - a prospective study.经蝶窦手术后无功能垂体腺瘤患者头痛的前瞻性研究。
Pituitary. 2024 Oct;27(5):635-643. doi: 10.1007/s11102-024-01401-3. Epub 2024 May 20.
6
The role of preoperative MRI in endoscopic transnasal transsphenoidal hypophysectomy of pituitary adenoma.术前磁共振成像在垂体腺瘤经鼻内镜经蝶窦垂体切除术中的作用。
Eur Arch Otorhinolaryngol. 2024 Apr;281(4):1961-1969. doi: 10.1007/s00405-024-08472-9. Epub 2024 Feb 6.
7
Immunohistochemical Analyses of Mammalian Target of Rapamycin (mTOR) Expression in Pituitary Neuroendocrine Tumors (PitNETs): mTOR as a Therapeutic Target for Functional PitNETs.垂体神经内分泌肿瘤(PitNETs)中雷帕霉素哺乳动物靶点(mTOR)表达的免疫组织化学分析:mTOR作为功能性PitNETs的治疗靶点
Acta Histochem Cytochem. 2023 Dec 28;56(6):121-126. doi: 10.1267/ahc.23-00039. Epub 2023 Dec 20.
8
Pathogenesis, clinical features, and treatment of plurihormonal pituitary adenoma.多激素垂体腺瘤的发病机制、临床特征及治疗
Front Neurosci. 2024 Jan 8;17:1323883. doi: 10.3389/fnins.2023.1323883. eCollection 2023.
9
Research progress on the role of the Wnt signaling pathway in pituitary adenoma.Wnt 信号通路在垂体腺瘤中作用的研究进展。
Front Endocrinol (Lausanne). 2023 Sep 14;14:1216817. doi: 10.3389/fendo.2023.1216817. eCollection 2023.
10
Prolactin and Growth Hormone Signaling and Interlink Focused on the Mammosomatotroph Paradigm: A Comprehensive Review of the Literature.聚焦于乳腺生长激素细胞范式的催乳素与生长激素信号传导及相互联系:文献综述
Int J Mol Sci. 2023 Sep 12;24(18):14002. doi: 10.3390/ijms241814002.